Sidra Medicine, a member of Qatar Foundation, will be hosting its first research-based symposium dedicated to maternal and child health from March 7 to 9 at the Qatar National Convention Centre (QNCC) in Doha.
The Maternal and Child Health Symposium (MCH) is based on the theme ‘From Clinical Research to Advanced Therapeutics and Precision Medicine’. It is being organised by the Research Branch at Sidra Medicine.
The Maternal and Child Health research at Sidra Medicine is aligned with Qatar’s National Health Strategy 2018-22 priority targets: Healthy women leading to healthy pregnancies. The MCH Symposium aims to provide an interdisciplinary platform to discuss the most recent developments, innovations and challenges related to maternal and child health as well as to promote and advance clinical practices in the field.
Dr. Souhaila Al Khodor, Chair of the MCH Symposium and Director of Maternal and Child Health Program, Research Branch, Sidra Medicine, said: “Pre-existing obesity is a major risk factor. Other non-communicable diseases such as diabetes, cardiovascular disease, metabolic syndrome and hypertension have also been cited with an alarmingly increasing rate in women during reproductive age. This also increases the risk of pregnancy- related complications.”
The MCH Symposium will cover both translational and clinical research with sessions looking at understanding the role of lifestyle and women’s health in fertility; the role of infectious and chronic diseases in reproductive health; as well as the latest updates on the novel tools and protocols used in IVF and in management of pregnancy complications.
Dr. Annalisa Terranegra, MCH Symposium Chair and Investigator in Nutritional Genomics and Metabolism, Research Division, Sidra Medicine, said “The MCH Symposium is further affirmation about Sidra Medicine’s efforts to enhance women’s health in Qatar both from a clinical and research perspective.”
The MCH Symposium 2020 has been approved for a maximum of 20.5 hours as an Accredited Group Learning Activity Category 1 as defined by the Qatar Council for Healthcare Practitioners- Accreditation Department (QCHP-AD). Deadline for abstract submissions (oral and poster presentations) is
February 15, 2020.
